Tenet Healthcare (THC) Tops Q4 EPS by 112c ; Offers Guidance

Tenet Healthcare (NYSE: THC) reported Q4 EPS of $2.68, $1.12 better than the analyst estimate of $1.56. Revenue for the quarter came in at $5.38 billion versus the consensus estimate of $5.27 billion.

GUIDANCE:

Tenet Healthcare sees Q1 2024 EPS of $1.24-$1.62, versus the consensus of $1.35. Tenet Healthcare sees Q1 2024 revenue of $5-5.2 billion, versus the consensus of $5.26 billion.

Tenet Healthcare sees FY2024 EPS of $5.76-$6.90, versus the consensus of $5.84. Tenet Healthcare sees FY2024 revenue of $19.9-20.3 billion, versus the consensus of $21.3 billion.

For earnings history and earnings-related data on Tenet Healthcare (THC) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• JPMorgan Upgrades Whitehaven Coal Ltd. (WHC:AU) (WHITF) to Overweight
• Guidewire Software (GWRE) Tops Q4 EPS by 6c; Offers Guidance